Pages that link to "Q68693121"
Jump to navigation
Jump to search
The following pages link to Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth (Q68693121):
Displaying 50 items.
- Enteric dysbiosis associated with a mouse model of alcoholic liver disease (Q24863915) (← links)
- A review of the medical treatment of primary sclerosing cholangitis in the 21st century (Q26771816) (← links)
- Alcoholic liver disease: the gut microbiome and liver cross talk (Q27025627) (← links)
- The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis (Q28348632) (← links)
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability (Q29617378) (← links)
- Microbial factors in inflammatory bowel disease (Q33337420) (← links)
- Hepatobiliary manifestations of inflammatory bowel disease (Q33662086) (← links)
- Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation (Q33663789) (← links)
- Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli (Q34001149) (← links)
- Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice (Q34006798) (← links)
- Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis (Q34170438) (← links)
- VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation (Q34428997) (← links)
- Alterations of the gut microbiome and metabolome in alcoholic liver disease (Q34508873) (← links)
- Prevention of parenteral nutrition-associated liver disease in children (Q34572743) (← links)
- Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"? (Q34796025) (← links)
- Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. (Q35134564) (← links)
- Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, bacteria, and bacterial polymers (Q35418279) (← links)
- Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth (Q35606574) (← links)
- Parenteral nutrition associated liver disease (Q35682617) (← links)
- Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease (Q35937716) (← links)
- Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease (Q35977446) (← links)
- Immunopathogenesis of primary sclerosing cholangitis (Q36119469) (← links)
- The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease (Q36310293) (← links)
- Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis (Q36589269) (← links)
- Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis (Q36809743) (← links)
- The potential role of phytochemicals in wholegrain cereals for the prevention of type-2 diabetes (Q36858730) (← links)
- Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth (Q36961213) (← links)
- Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice (Q36961744) (← links)
- Inflammatory bowel disease. Part II: Clinical and therapeutic aspects (Q37437819) (← links)
- Hepatobiliary injury associated with experimental small-bowel bacterial overgrowth in rats (Q37532339) (← links)
- Animal models of intestinal and joint inflammation (Q38563435) (← links)
- Alcoholic hepatitis: The pivotal role of Kupffer cells (Q38645785) (← links)
- Current concepts in primary sclerosing cholangitis (Q40636792) (← links)
- Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice (Q41680744) (← links)
- Review article: How relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? (Q41703215) (← links)
- Small duct cholangitis induced by N-formyl L-methionine L-leucine L-tyrosine in rats (Q42283078) (← links)
- Effects of Ganoderma lucidum on obstructive jaundice-induced oxidative stress. (Q42747361) (← links)
- Recurrence and rejection in liver transplantation for primary sclerosing cholangitis (Q43046283) (← links)
- Hepatic decompensation after gastric bypass surgery for severe obesity (Q43481491) (← links)
- Cutting Edge Issues in Primary Sclerosing Cholangitis (Q44391213) (← links)
- Ursodeoxycholate further increases bile-duct cell proliferative response induced by partial bile-duct ligation in rats (Q44835576) (← links)
- Sclerosing cholangitis in children (Q45087488) (← links)
- Primary sclerosing cholangitis: diagnostic and management challenges (Q47112995) (← links)
- BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis (Q48003458) (← links)
- The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation (Q49799963) (← links)
- Molecular MR Imaging of Myeloperoxidase Distinguishes Steatosis from Steatohepatitis in Nonalcoholic Fatty Liver Disease (Q51081040) (← links)
- High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis (Q51453492) (← links)
- Surgical manipulation of the intestine results in quantitative and qualitative alterations in luminal Escherichia coli. (Q54502410) (← links)
- Effects of yeast cell wall on growth performance, immune responses and intestinal short chain fatty acid concentrations of broilers in an experimental necrotic enteritis model. (Q54966784) (← links)
- Antimicrobial proteins: intestinal guards to protect against liver disease (Q58614336) (← links)